Amyotrophic lateral sclerosis (ALS) is identified histologically by the deposition of phosphorylated 43-kDa transactive response DNA-binding protein (pTDP-43). The progression of this ALS pathology through the brain has been staged pathologically using autopsy samples, and through white matter tracts using diffusion tensor imaging (DTI). A model of corticofugal axonal spread proposes that pTDP-43 aggregates spread to grey matter regions sequentially through connecting white matter tracts. The aims of this thesis were to validate the neuropathological staging scheme of pTDP-43 pathology in a representative cohort of ALS patients, investigate the cellular mechanisms underlying disease spread through white matter tracts, and to test the theory...
Altres ajuts:Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innova...
Background: Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disease. TDP-43 is fou...
Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several ...
AbstractAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by p...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by progressi...
International audienceTransactivation response DNA binding protein 43 kDa (TDP-43) is known to be a ...
Objective Emerging evidences suggest that the trans-neural propagation of phosphorylated 43-kDa tran...
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegen...
OBJECTIVE: The aim of this study was to test the hypothesis that white matter degeneration of the pe...
Objective: The aim of this study was to test the hypothesis that white matter degeneration of the pe...
A sequential transaxonal disease spread of amyotrophic lateral sclerosis (ALS)-associated TDP-43 pa...
The âselective vulnerabilityâ of cells and systems to disease pathomechanisms is a defining feature ...
The discovery that most pathological protein inclusions in amyotrophic lateral sclerosis (ALS) and f...
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects corticospinal and ...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneou...
Altres ajuts:Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innova...
Background: Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disease. TDP-43 is fou...
Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several ...
AbstractAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by p...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by progressi...
International audienceTransactivation response DNA binding protein 43 kDa (TDP-43) is known to be a ...
Objective Emerging evidences suggest that the trans-neural propagation of phosphorylated 43-kDa tran...
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegen...
OBJECTIVE: The aim of this study was to test the hypothesis that white matter degeneration of the pe...
Objective: The aim of this study was to test the hypothesis that white matter degeneration of the pe...
A sequential transaxonal disease spread of amyotrophic lateral sclerosis (ALS)-associated TDP-43 pa...
The âselective vulnerabilityâ of cells and systems to disease pathomechanisms is a defining feature ...
The discovery that most pathological protein inclusions in amyotrophic lateral sclerosis (ALS) and f...
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative condition that affects corticospinal and ...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneou...
Altres ajuts:Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innova...
Background: Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disease. TDP-43 is fou...
Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several ...